The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation
Open accessAbstract
The purpose of this article was to examine historic institutional autologous stem cell mobilization practices and evaluate factors influencing mobilization failure and kinetics. In this retrospective study we analyzed clinical records of 1834 patients who underwent stem cell mobilization for autologous transplantation from November 1995 to October 2006 at the Washington University in St. Louis. Successful mobilization was defined as collection of > or =2 x 10(6) CD34(+) cells/kg. From 1834 consecutive patients, 1040 met our inclusion criteria (502 non-Hodgkin's lymphoma [NHL], 137 Hodgkin's lymphoma, and 401 multiple myeloma [MM]). A total of 976 patients received granulocyte colony-stimulating factor (G-CSF) and 64 received G-CSF plus chemotherapy (G/C) for the initial mobilization. Although the median CD34(+) cell yield was higher in G/C group than in G-CSF alone group, the failure rates were similar: 18.8% and 18.6%, respectively. Overall, 53% of patients collected > or =2 x 10(6) CD34(+) cells/kg during the first apheresis with either mobilization regimen. Regardless of mobilization regimen used, MM patients had the highest total CD34(+) cell yield and required less aphereses to collect > or =2 x 10(6) CD34(+) cells/kg. Mobilized, preapheresis, peripheral blood CD34(+) count correlated with first day apheresis yield (r = .877, P < .001) and 20 cells/microL was the minimum threshold needed for a successful day 1 collection. For the remobilization analysis we included patients from the whole database. A total of 269 of 1834 patients underwent remobilization using G/C, G-CSF, and/or GM-CSF, and G-CSF plus plerixafor. Only 23% of remobilized patients achieved > or =2 x 10(6) CD34(+) cells/kg and 29.7% failed to pool sufficient number of stem cells from both collections. Patients receiving G-CSF plus plerixafor had lowest failure rates, P = .03. NHL patients remobilized with G-CSF who waited > or =25 days before remobilization had lower CD34(+) cell yield than those who waited < or =16 days, P = .023. Current mobilization regimens are associated with a substantial failure rate irrespective of underlying disease. Patients who fail initial mobilization are more likely to fail remobilization. These findings suggest that there is a need for more effective first-line mobilization agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., Brown, J., Drayson, M. T., & Selby, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022340 · Cited by 1,768
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
SUTHERLAND, D. R., ANDERSON, L., KEENEY, M., NAYAR, R., & CHIN-YEE, I. (1996) · Journal of Hematotherapy · doi:10.1089/scd.1.1996.5.213 · Cited by 1,275
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Simmons, P. J., & Bendall, L. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15994 · Cited by 761
The Biology and Clinical Uses of Blood Stem Cells
To, L. B., Haylock, D. N., Simmons, P. J., & Juttner, C. A. (1997) · Blood · doi:10.1182/blood.v89.7.2233 · Cited by 689
Weaver, C. H., Hazelton, B. J., Birch, R., Palmer, P. A., Allen, C., Schwartzberg, L. S., & West, W. H. (1995) · Blood · doi:10.1182/blood.v86.10.3961.bloodjournal86103961 · Cited by 612
Schmitz, N., Dreger, P., Linch, D. C., Goldstone, A. H., Boogaerts, M. A., Demuynck, H. M. S., Ferrant, A., Zander, A., Link, H., Barge, A., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90536-x · Cited by 610
G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow
Semerad, C. L., Christopher, M. J., Liu, F., Short, B., Simmons, P. J., Winkler, I., Levesque, J.-P., Chappel, J., Ross, F. P., & Link, D. C. (2005) · Blood · doi:10.1182/blood-2004-01-0272 · Cited by 500
Flomenberg, N. (2005) · Blood · doi:10.1182/blood-2005-02-0468 · Cited by 460
Tricot, G. J. K., Jagannath, S., Vesole, D. H., Nelson, J., Tindle, S., Miller, L., Cheson, B. D., Crowley, J. J., & Barlogie, B. (1995) · Blood · doi:10.1182/blood.v85.2.588.588 · Cited by 452
Devine, S. M., Flomenberg, N., Vesole, D. H., Liesveld, J., Weisdorf, D., Badel, K., Calandra, G., & DiPersio, J. F. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.131 · Cited by 368
Self-citationKumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Gastineau, D. A., Litzow, M. R., Fonseca, R., Roy, V, Rajkumar, S. V., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404801 · Cited by 351
Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy
Siena, S., Schiavo, R., Pedrazzoli, P., & Carlo-Stella, C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1360 · Cited by 312
Lévesque, J.-P., Hendy, J., Takamatsu, Y., Williams, B., Winkler, I. G., & Simmons, P. J. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00788-9 · Cited by 289
Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., et al. (2000) · Blood · doi:10.1182/blood.v95.5.1588.005k38_1588_1593 · Cited by 285
Beyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwaner, I., Oettle, H., Serke, S., Huhn, D., & Stieger, W. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1328 · Cited by 269
Calandra, G., McCarty, J., McGuirk, J., Tricot, G., Crocker, S.-A., Badel, K., Grove, B., Dye, A., & Bridger, G. (2008) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705908 · Cited by 250
Characterization of hematopoietic progenitor mobilization in protease-deficient mice
Levesque, J.-P., Liu, F., Simmons, P. J., Betsuyaku, T., Senior, R. M., Pham, C., & Link, D. C. (2004) · Blood · doi:10.1182/blood-2003-05-1589 · Cited by 240
Hartmann, O., Corroller, A. G. L., Blaise, D., Michon, J., Philip, I., Norol, F., Janvier, M., Pico, J. L., Baranzelli, M. C., Rubie, H., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00002 · Cited by 231
Dreger, P., Kloss, M., Petersen, B., Haferlach, T., Loffler, H., Loeffler, M., & Schmitz, N. (1995) · Blood · doi:10.1182/blood.v86.10.3970.bloodjournal86103970 · Cited by 225
Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry.
Sutherland, D. R., Keating, A., Nayar, R., Anania, S., & Stewart, A. K. (1994) · PubMed · Cited by 195
Desikan, K. R., Barlogie, B., Jagannath, S., Vesole, D. H., Siegel, D. S. D., Fassas, A., Munshi, N. C., Singhal, S., Mehta, J., Tindle, S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1547 · Cited by 156
Narayanasami, U., Kanteti, R., Morelli, J., Klekar, A., Al-Olama, A., Keating, C. L., O'Connor, C., Berkman, E. M., Erban, J. K., Sprague, K., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2059 · Cited by 156
Alegre, A. M., Tomás, J., Martínez‐Chamorro, C., Gil‐Fernández, J. J., Fernández-Villalta, M. J., Arranz, R., Díaz, M. Á., Granda, A., Bernardo, M. P., Escudero, A., et al. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700867 · Cited by 136
Winkler, I. G., Hendy, J., Coughlin, P., Horvath, A. J., & Lévesque, J.-P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042299 · Cited by 104
Koç, O. N., Gerson, S. L., Cooper, B., Laughlin, M., Meyerson, H. J., Kutteh, L. A., Fox, R. M., Szekely, E., Tainer, N., & Lazarus, H. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1824 · Cited by 94
Passos‐Coelho, J. L., Braine, H., Davis, J. M., Huelskamp, A. M., SCHEPERS, K. G., Ohly, K. V., Clarke, B., Wright, S. K., Noga, S. J., & Davidson, N. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.705 · Cited by 91
Dingli, D., Nowakowski, G. S., Dispenzieri, A. A., Lacy, M. Q., Hayman, S. R., Litzow, M. R., Gastineau, D. A., & Gertz, M. A. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.n.014 · Cited by 90
Perea, G., Sureda, A. M., Martino, R., Altés, A., Martínez, C., Cabezudo, M.-E., Amill, B., n-Henao, G. M. X. E., lez, Y. G. X. E., Muñoz, L., et al. (2001) · Annals of Hematology · doi:10.1007/s002770100351 · Cited by 81
Bolwell, B. J., Pohlman, B. L., Rybicki, L. A., Sobecks, R. M., Dean, R. M., Curtis, J., Andresen, S., Koo, A. P., Mineff, V., Kalaycio, M. E., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705763 · Cited by 79
Weaver, C. H., Tauer, K. W., Zhen, B., Schwartzberg, L. S., Hazelton, B. J., WEAVER, Z., Lewkow, L. M., ALLEN, C., Longin, K., & Buckner, C. D. (1998) · Journal of Hematotherapy · doi:10.1089/scd.1.1998.7.241 · Cited by 58
Solá, C., Maroto, P., Salazar, R., Mesı́a, R., Mendoza, L., Brunet, J., Pousa, A. L., Tabernero, J. M., Montesinos, J., Pericay, C., et al. (1999) · Hematology · doi:10.1080/10245332.1999.11746443 · Cited by 43
Mobilization and collection of autologous hematopoietic progenitor/stem cells.
Montgomery, M., & Cottler‐Fox, M. (2007) · PubMed · Cited by 36
Beguin, Y. P., Baudoux, É., Sautois, B. R., Fraipont, V., Schaaf‐Lafontaine, N., Pereira, M., Paulus, J. M., Sondag, D., & Fillet, G. (1998) · Transfusion · doi:10.1046/j.1537-2995.1998.38298193106.x · Cited by 28
Gupta, S., Zhou, P. H., Hassoun, H., Kewalramani, T., REICH, L. M., Costello, S., Drake, L., Klimek, V. M., Dhodapkar, M. V., Teruya‐Feldstein, J., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704779 · Cited by 21
Cashen, A. F., Calandra, G. C., MacFarland, R. T., Lopez, S., & DiPersio, J. F. (2006) · Blood · doi:10.1182/blood.v108.11.3053.3053 · Cited by 6
Self-citation
Cited by
Hematopoietic stem cell niche maintenance during homeostasis and regeneration
Mendelson, A., & Frenette, P. S. (2014) · Nature Medicine · doi:10.1038/nm.3647 · Cited by 792
Giralt, S., Costa, L., Schriber, J., DiPersio, J., Maziarz, R., McCarty, J., Shaughnessy, P., Snyder, E., Bensinger, W., Copelan, E., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2013.10.013 · Cited by 407
Self-citationDiabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function
Ferraro, F., Lymperi, S., Méndez-Ferrer, S., Saez, B., Spencer, J. A., Yeap, B. Y., Masselli, E., Graiani, G., Prezioso, L., Rizzini, E. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002191 · Cited by 296
Wuchter, P., Ran, D., Bruckner, T., Schmitt, T., Witzens-Harig, M., Neben, K., Goldschmidt, H., & Ho, A. D. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.11.012 · Cited by 267
Metadata
- Authors
- Pusic, I., Jiang, S. Y., Landua, S., Uy, G. L., Rettig, M. P., Cashen, A. F., Westervelt, P., Vij, R., Abboud, C. N., Stockerl-Goldstein, K. E., Sempek, D. S., Smith, A. L., & DiPersio, J. F.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 14
- Issue
- 9
- Pages
- 1045-1056
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2009299193
- Cited by
- 352
- References
- 37
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.